drugset / Trial / NCT00463320

A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects.

NCT00463320

Phase 1 Completed 29 enrolled GlaxoSmithKline
RandomizedParallel-groupSingle-blindDiagnostic

Summary

This is a two-part study to evaluate the safety, tolerability and pharmacokinetics of single (Part A) and repeat (Part B) eye drop doses of pazopanib in healthy adult and elderly subjects.

Timeline

Start
2007-03
Primary completion
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Pazopanib Small molecule Topical